phenyl acetate has been researched along with Infectious Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biffi, A; Blijlevens, N; de la Camara, R; Fagioli, F; Galaverna, F; Gil, L; Groll, AH; Holler, E; Junghanss, C; Knelange, N; Lioure, B; Ljungman, P; Medinger, M; Mielke, S; Mikulska, M; Nikolousis, E; Rodriguez, MAB; Solano, C; Šrámek, J; Styczyński, J; Taskinen, M; Tridello, G; Tsirigotis, P; Wendel, L; Xhaard, A | 1 |
1 other study(ies) available for phenyl acetate and Infectious Diseases
| Article | Year |
|---|---|
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
Topics: Acetates; Adult; Antiviral Agents; Bone Marrow; Child; Communicable Diseases; Cytomegalovirus; Hematopoietic Stem Cell Transplantation; Humans; Off-Label Use; Quinazolines; Retrospective Studies | 2021 |